WRF
NEOS

Waddell & Reed Financial’s Neos Therapeutics, Inc NEOS Stock Holding History

Waddell & Reed Financial’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40,000
Closed -$840K – 659
2015
Q3 		$840K Buy
+40,000
New +$881K ﹤0.01% 604

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Waddell & Reed Financial's NEOS Position: Q4 2015 in Review

Waddell & Reed Financial sold out of Neos Therapeutics, Inc (NEOS) in Q4 2015, closing a stake of 40,000 shares — an estimated $840K sold.

Waddell & Reed Financial first reported a position in NEOS in Q3 2015 and held it in 1 quarter. The position peaked at $840K in Q3 2015. 45 funds tracked by Wall St. Rank hold NEOS as of Q4 2015.

  • Waddell & Reed Financial reported no remaining Neos Therapeutics, Inc position as of Q4 2015 after selling out during the quarter.
  • Waddell & Reed Financial sold 40,000 Neos Therapeutics, Inc shares in Q4 2015, an estimated $840K.
  • Waddell & Reed Financial first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 1 quarter.
  • Waddell & Reed Financial's Neos Therapeutics, Inc position peaked at $840K in Q3 2015.
  • 45 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2015.

Based on Waddell & Reed Financial's 13F filing for Q4 2015, filed 12 Feb 2016.